Detalhe da pesquisa
1.
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38843860
2.
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
Lancet
; 403(10435): 1460-1471, 2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554725
3.
A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events.
Br J Cancer
; 129(4): 612-619, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37419999
4.
A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
Br J Cancer
; 128(1): 30-41, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335217
5.
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.
Br J Cancer
; 129(2): 309-317, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237172
6.
Desmoid Tumors in Familial Adenomatous Polyposis Patients: Favorable Outcomes with Multidisciplinary Management.
Ann Surg Oncol
; 30(8): 5142-5149, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237094
7.
Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE.
Br J Cancer
; 127(9): 1629-1635, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36008705
8.
Canadian consensus on TRK-inhibitor therapy for NTRK fusion-positive sarcoma.
Int J Cancer
; 149(9): 1691-1704, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34213775
9.
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.
Cancer
; 127(16): 2934-2942, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33910263
10.
Selinexor, a First in Class, Nuclear Export Inhibitor for the Treatment of Advanced Malignant Peripheral Nerve Sheath Tumor.
Oncologist
; 26(4): e710-e714, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512749
11.
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma.
Future Oncol
; 17(22): 2923-2939, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33855868
12.
Curability of patients with lymph node metastases from extremity soft-tissue sarcoma.
Cancer
; 126(23): 5098-5108, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32910462
13.
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs.
Cancer
; 126(7): 1550-1558, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31914209
14.
A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors.
Invest New Drugs
; 38(4): 1156-1165, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31734832
15.
High prevalence of persistent emotional distress in desmoid tumor.
Psychooncology
; 29(2): 311-320, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31778588
16.
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.
JAMA
; 323(13): 1266-1276, 2020 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32259228
17.
Hyperprogressive disease in early-phase immunotherapy trials: Clinical predictors and association with immune-related toxicities.
Cancer
; 125(8): 1341-1349, 2019 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30768786
18.
Feasibility Assessment of Using the Complete Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library.
Oncologist
; 24(4): e146-e148, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30728278
19.
Referrals to a Phase I Clinic and Trial Enrollment in the Molecular Screening Era.
Oncologist
; 24(7): e518-e525, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30833487
20.
Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.
Int J Cancer
; 142(1): 57-65, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28891048